For example, polymorphisms in ERCC1 and XRCC1, implicated in nucleotide excision repair and base excision repair and therefore key in DNA repair mechanisms, have been associated with a better response in patients suffering NSCLC treated with Pt-compounds [27,28]. This evidence concerns the gene ERCC1 and non-small cell lung carcinoma.